Effective oral hypomethylating drugs in intermediate-risk or high-risk myelodysplasia: a breakthrough?

Publication date: April 2019Source: The Lancet Haematology, Volume 6, Issue 4Author(s): Theo de Witte

Source: The Lancet Haematology - March 28, 2019 Category: Hematology Source Type: research